Amanita Muscaria extract, Calm
Psyched Wellness proprietary Amanita Muscaria extract, Calm
  • Psyched Wellness (PSYC) has launched a new, larger bottle size of Calm, their proprietary Amanita Muscaria extract
  • This new size offers double the servings per bottle in a 60ml package at a launch price of $74.99 USD
  • This new size aims to provide users with a practical way to take Calm on a daily basis, increasing convenience and affordability
  • Psyched Wellness is a Canadian-based health supplements company
  • Psyched Wellness Ltd (PSYC) is up 8.33 per cent, trading at C$0.065 per share at 11:09 am ET

Psyched Wellness (PSYC) has launched a new, larger bottle size of Calm, their proprietary Amanita Muscaria extract.

This new size offers double the servings per bottle in a 60ml package at a launch price of $74.99 USD. Calm is the first legal Amanita Muscaria extract available for sale in the USA, which can facilitate restful sleep.

This new size aims to provide users with a practical way to take Calm on a daily basis, increasing convenience and affordability. According to the company, it allows users to now take twice as many servings of Calm per bottle as before.

Matthew Singh, Chief Commercial Officer of Psyched Wellness, commented on the news.

“We are excited to provide our customers with an opportunity to try out our product at an increased volume and lower cost per serving. With so many people looking for ways to manage their sleep and overall health, we wanted to make sure that we could offer them a high-quality product at an affordable price point.”

About Psyched Wellness Ltd

Psyched Wellness is a Canadian-based health supplements company. It focuses on the distribution of mushroom-derived products and associated consumer packaged goods.

The company is in the process of developing a line of Amanita muscaria-derived water-based extracts, teas and capsules. With these products, the company aims to help promote stress relief and relaxation and assist with restful sleeping.

Psyched Wellness Ltd (PSYC) is up 8.33 per cent, trading at C$0.065 per share at 11:09 am ET.


More From The Market Online

Theralase adds cancer immunotherapy to potential revenue streams

Theralase Technologies' (TSXV:TLT) lead drug candidate, Rutherrin, enhanced cancer immunotherapy in a pre-clinical setting.

From robotic limbs to new highs, NVIDIA stock is on a roll

NVIDIA Corp. (NDAQ:NVDA; NEO:NVDA) opens Tuesday trading on a positive note, showing a significant upward trend.

Western Alaska Minerals begins drilling in Alaska

Western Alaska Minerals (TSXV:WAM) begins drilling at its 100-per-cent-owned Illinois Creek property in Western Alaska.